• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PML 在 IFN-α诱导的人间质基质细胞细胞衰老中的关键作用。

The key role of PML in IFN-α induced cellular senescence of human mesenchymal stromal cells.

机构信息

Bone Marrow Transplantation Center, The First Affiliated Hospital, Medical School of Zhejiang University, Hangzhou 310003, P.R. China.

Zhejiang Cancer Hospital, Hangzhou 310022, P.R. China.

出版信息

Int J Oncol. 2015 Jan;46(1):351-9. doi: 10.3892/ijo.2014.2738. Epub 2014 Oct 30.

DOI:10.3892/ijo.2014.2738
PMID:25354534
Abstract

Recent developments and re-emergence of interferon α (IFN-α) have renewed interest in the therapy for patients with chronic myeloid leukemia (CML). Related molecular mechanism may be the direct effect of IFN-α on CML stem cells. Human mesenchymal stromal cells (hMSCs) are important to protect CML stem cells, and IFN-α was described as a potential inhibitor of hMSCs. However, the exact mechanism remains obscure. PML as a known tumor suppressor locates downstream of the IFN-α pathway, and little is known about the PML gene regulation in hMSCs. The aim of this study was to investigate the effects of IFN-α on hMSCs and defined the role of PML involved in this process. Our results suggested that hMSCs incurred senescence upon IFN-α stimulation, while PML levels were observed significant increased. The recombinant lentiviral vector, which encodes shRNA against PML or full-length PML cDNA, was constructed. By knocking-down and overexpressing PML, we found that PML was indispensable to IFN-α mediated hMSC senescence. The molecular mechanism underlying this process may be an increased co-localization of PML and p53 induced by IFN-α. Our data demonstrated that IFN-α can induce cellular senescence of hMSCs and PML plays a key role in this process. These findings provided novel insight into the effect of IFN-α on hMSCs.

摘要

干扰素 α(IFN-α)的最新进展和再次出现重新引起了人们对慢性髓系白血病(CML)患者治疗的兴趣。相关的分子机制可能是 IFN-α对 CML 干细胞的直接作用。人间质基质细胞(hMSC)对于保护 CML 干细胞很重要,IFN-α被描述为 hMSC 的潜在抑制剂。然而,确切的机制仍不清楚。PML 作为已知的肿瘤抑制因子,位于 IFN-α通路的下游,关于 PML 基因在 hMSC 中的调控知之甚少。本研究旨在探讨 IFN-α对 hMSC 的影响,并确定 PML 在该过程中所涉及的作用。我们的结果表明,IFN-α刺激 hMSC 衰老,而 PML 水平明显增加。构建了编码针对 PML 的 shRNA 或全长 PML cDNA 的重组慢病毒载体。通过敲低和过表达 PML,我们发现 PML 对于 IFN-α 介导的 hMSC 衰老至关重要。该过程的分子机制可能是 IFN-α诱导的 PML 和 p53 的共定位增加。我们的数据表明,IFN-α可诱导 hMSC 细胞衰老,而 PML 在该过程中起关键作用。这些发现为 IFN-α对 hMSC 的影响提供了新的见解。

相似文献

1
The key role of PML in IFN-α induced cellular senescence of human mesenchymal stromal cells.PML 在 IFN-α诱导的人间质基质细胞细胞衰老中的关键作用。
Int J Oncol. 2015 Jan;46(1):351-9. doi: 10.3892/ijo.2014.2738. Epub 2014 Oct 30.
2
Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.Pml与TAp73在核体相互作用介导伊马替尼诱导的慢性髓性白血病细胞非p53依赖的凋亡。
Int J Cancer. 2009 Jul 1;125(1):71-7. doi: 10.1002/ijc.24329.
3
PML overexpression inhibits proliferation and promotes the osteogenic differentiation of human mesenchymal stem cells.PML 过表达抑制人骨髓间充质干细胞增殖并促进其成骨分化。
Oncol Rep. 2013 Dec;30(6):2785-94. doi: 10.3892/or.2013.2786. Epub 2013 Oct 3.
4
PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.早幼粒细胞白血病蛋白通过调节肿瘤坏死因子相关凋亡诱导配体的诱导来介导干扰素-α诱导的骨髓瘤细胞凋亡。
Blood. 2005 Feb 1;105(3):1280-7. doi: 10.1182/blood-2004-04-1614. Epub 2004 Sep 30.
5
Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.敲低早幼粒细胞白血病蛋白(PML)会损害p53信号转导通路,并抑制辐射诱导的乳腺癌细胞MCF-7凋亡。
J Cell Biochem. 2006 Feb 15;97(3):561-71. doi: 10.1002/jcb.20584.
6
Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.丙型肝炎病毒核心蛋白抑制人肝癌细胞中肿瘤抑制蛋白早幼粒细胞白血病的功能。
Cancer Res. 2005 Dec 1;65(23):10830-7. doi: 10.1158/0008-5472.CAN-05-0880.
7
IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53.α干扰素诱导的肝癌细胞凋亡独立于p53,涉及早幼粒细胞白血病蛋白和肿瘤坏死因子相关凋亡诱导配体。
Cancer Res. 2009 Feb 1;69(3):855-62. doi: 10.1158/0008-5472.CAN-08-2831. Epub 2009 Jan 13.
8
Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth.端粒酶抑制引发 PML 依赖性 p53 激活以抑制膀胱癌细胞生长。
Oncol Rep. 2010 Dec;24(6):1551-9. doi: 10.3892/or_00001017.
9
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.早幼粒细胞白血病蛋白(PML)调控由致癌性Ras诱导的p53乙酰化和早衰。
Nature. 2000 Jul 13;406(6792):207-10. doi: 10.1038/35018127.
10
A CK2-dependent mechanism for degradation of the PML tumor suppressor.一种依赖CK2的PML肿瘤抑制因子降解机制。
Cell. 2006 Jul 28;126(2):269-83. doi: 10.1016/j.cell.2006.05.041.

引用本文的文献

1
Transcriptomic analysis of cellular senescence induced by ectopic expression of ATF6α in human breast cancer cells.人乳腺癌细胞中 ATF6α 异位表达诱导细胞衰老的转录组分析。
PLoS One. 2024 Oct 28;19(10):e0309749. doi: 10.1371/journal.pone.0309749. eCollection 2024.
2
TNF-α and IFN-γ Participate in Improving the Immunoregulatory Capacity of Mesenchymal Stem/Stromal Cells: Importance of Cell-Cell Contact and Extracellular Vesicles.TNF-α 和 IFN-γ 参与改善间充质干细胞/基质细胞的免疫调节能力:细胞-细胞接触和细胞外囊泡的重要性。
Int J Mol Sci. 2021 Sep 2;22(17):9531. doi: 10.3390/ijms22179531.
3
NHP2 downregulation counteracts hTR-mediated activation of the DNA damage response at ALT telomeres.
NHP2表达下调可抵消hTR介导的在端粒延长(ALT)型端粒处的DNA损伤反应激活。
EMBO J. 2021 Mar 15;40(6):e106336. doi: 10.15252/embj.2020106336. Epub 2021 Feb 17.
4
Type I interferons and related pathways in cell senescence.I 型干扰素及相关通路在细胞衰老中的作用。
Aging Cell. 2020 Oct;19(10):e13234. doi: 10.1111/acel.13234. Epub 2020 Sep 12.
5
Bone mesenchymal stromal cells exhibit functional inhibition but no chromosomal aberrations in chronic myelogenous leukemia.骨髓间充质基质细胞在慢性粒细胞白血病中表现出功能抑制,但无染色体畸变。
Oncol Lett. 2019 Jan;17(1):999-1007. doi: 10.3892/ol.2018.9681. Epub 2018 Nov 9.
6
p53 as an Effector or Inhibitor of Therapy Response.p53作为治疗反应的效应因子或抑制剂
Cold Spring Harb Perspect Med. 2015 Dec 4;6(1):a026260. doi: 10.1101/cshperspect.a026260.